SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001594864-16-000006
Filing Date
2016-11-09
Accepted
2016-11-09 17:07:06
Documents
78
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q juno-09302016x10q.htm 10-Q 1408063
2 EXHIBIT 31.1 ex-311x09302016.htm EX-31.1 12904
3 EXHIBIT 31.2 ex-312x09302016.htm EX-31.2 12374
4 EXHIBIT 32.1 ex-321x09302016.htm EX-32.1 7402
5 EXHIBIT 32.2 ex-322x09302016.htm EX-32.2 7404
  Complete submission text file 0001594864-16-000006.txt   6731309

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT juno-20160930.xml EX-101.INS 1444224
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT juno-20160930.xsd EX-101.SCH 52115
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT juno-20160930_cal.xml EX-101.CAL 83195
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT juno-20160930_def.xml EX-101.DEF 280252
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT juno-20160930_lab.xml EX-101.LAB 569997
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT juno-20160930_pre.xml EX-101.PRE 424928
Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Filer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36781 | Film No.: 161985090
SIC: 2836 Biological Products, (No Diagnostic Substances)